The global Biosimulation Market size was valued at USD 4.31 Billion in 2022 and is projected to reach USD 16.69 Billion by 2030, growing at a CAGR of 16.23 % from 2024 to 2032. The biosimulation market is an innovative sector within the life sciences and biopharmaceutical industries, focusing on the use of computational models to simulate biological processes. These simulations assist in drug...